President and Chief Executive Officer
Jeffrey A. Duchemin was appointed Chief Executive Officer on August 26, 2013. Mr. Duchemin assumed the additional roles of President on November 1, 2013 and Director on October 29, 2013. Prior to joining Harvard Bioscience, Mr. Duchemin spent 16 years with Becton Dickinson (“BD”) in progressive sales, marketing and executive leadership positions across BD’s three business segments; BD Medical Systems, BD Diagnostic Systems, and BD Biosciences. In October 2012, BD Biosciences Discovery Labware was acquired by Corning Life Sciences. Mr. Duchemin was a Global Business Director for Corning Life Sciences until his recent departure to Harvard Bioscience. Mr. Duchemin is a transformational leader with demonstrated business results. The depth of his experience spans across a broad range of life science research and medical device products resulting in growth on a global basis. Mr. Duchemin earned an M.B.A. from Southern New Hampshire University and a B.S. in accounting from the University of Massachusetts Dartmouth.
Chief Financial Officer
VP Commercial Operations
Mr. Sun assumed the role of VP Commercial Operations on October 28, 2015. Previously Mr. Sun held the position of VP Strategic Marketing, Business Development and R&D since October 28, 2013. Prior to joining Harvard Bioscience, he served as Vice President of Global Marketing and Americas Sales at Beaver-Visitec International, a company combining former ophthalmic business units from Becton, Dickinson & Company (BD) and Medtronic; in this role he led global marketing to develop and implement strategic marketing plans in target surgical markets. Prior to this, he served in progressive positions at BD, including Director of Global Marketing & U.S. Sales. Earlier, he served as Marketing Manager, Global Life Sciences Market & Greater China Region at Eli Lilly & Company’s eLilly Unit (now InnoCentive, Inc.). Mr. Sun, holds an M.B.A. from the MIT Sloan School of Management, a master of science degree in environmental science & engineering from Northeastern University and a bachelor of science degree in biochemistry from Peking University.
VP Global Operations and Quality
Mr. Aplin was appointed VP Global Operations and Quality on March 10, 2014. Mr. Aplin has more than 25 years experience in operations and supply chain management. He comes to Harvard Bioscience from Corning Incorporated, where he served as Operations/Plant Manager since 2012. Prior to Corning, he worked as Director of Operations at Becton, Dickinson and Company. Earlier, he served as Plant Manager at Teleflex Medical, as well as senior operational roles in the petrochemical industry. He holds a bachelor’s degree from the University of South Alabama and a master of arts degree in organizational management from the University of Phoenix.
VP Sales, Denville Scientific
Mr. Atienza was appointed VP of Sales at Denville Scientific on February 18, 2015. Mr. Atienza brings more than a decade of experience working for healthcare and global life sciences companies, including selling life science consumables, instruments and equipment both direct and via distributors. Prior to joining Harvard Bioscience, he served as Manager, Business Development with American Express – Healthcare Solutions. Prior to this, he served as Director, Ophthalmic Business Consulting Group for Essilor of America, the leading manufacturer and wholesale distributor of optical lenses in the U.S. Earlier, from 2002 to 2012, he served in progressive sales leadership positions at Beaver-Visitec International, a company combining former ophthalmic business units from Becton, Dickinson & Company and Medtronic. Mr. Atienza holds an M.B.A. from Wake Forest University School of Business and B.A. in biology from Appalachian State University.